← Product Code [EIH](/productcode/EIH) · K130198

# NEO DENTA ZIRCONIA (K130198)

_Neo Group Limited · EIH · Oct 21, 2013 · Dental · SESE_

**Canonical URL:** https://fda-staging.innolitics.com/device/K130198

## Device Facts

- **Applicant:** Neo Group Limited
- **Product Code:** [EIH](/productcode/EIH.md)
- **Decision Date:** Oct 21, 2013
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 872.6660
- **Device Class:** Class 2
- **Review Panel:** Dental

## Indications for Use

Remedial Blanks for the Fabrication of Dental Restoration

## Device Story

Neo Denta Zirconia is a partially sintered yttrium oxide stabilized zirconium dioxide disc. Used in dental laboratories as a material for dental restoration; serves as an alternative to gold, porcelain, and other ceramics. The disc is milled into various shapes of prostheses using CAD/CAM systems. The device is a relabeled version of the Sagemax Z-Blank; it shares identical material composition, dimensions, and physical properties. No clinical testing was performed; substantial equivalence is based on identical technological characteristics to the predicate.

## Clinical Evidence

No clinical data provided. Substantial equivalence is supported by bench testing, including particle size measurement, chemical composition analysis (EDS/X-ray), and mechanical testing (3-point and biaxial flexural strength/toughness).

## Technological Characteristics

Partially sintered yttrium oxide stabilized zirconium dioxide disc. Form factor: milling blank. Properties verified via laser scanning, EDS, X-ray, and spectrophotometry. Mechanical testing performed via 3-point and biaxial flexural strength tests.

## Regulatory Identification

Porcelain powder for clinical use is a device consisting of a mixture of kaolin, felspar, quartz, or other substances intended for use in the production of artificial teeth in fixed or removable dentures, of jacket crowns, facings, and veneers. The device is used in prosthetic dentistry by heating the powder mixture to a high temperature in an oven to produce a hard prosthesis with a glass-like finish.

## Predicate Devices

- Sagemax Z-Blank (Z062695)

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

## 510(k) Summary

- Mike Adams, Q1D G/F Kaiser 3ra Phase, 18 Man Lok Street, Hung Hom, Submitter: Kowloon, Hong Kong.
- l. Classification Names: Porcelain powder for Clinical use, ElH
- ll. Requlation Number: CFR 872.6660
- III. Common/ Usual Name: Zirconia disc, porcelain material for dental restoration
- IV. Proprietary Names: Neo Denta Zirconia
- V. Establishment Registration Number: In Process
- VI. Device description: Neo Denta Zirconia is a partially sintered zirconia disc, which is vttrium oxide stabilized zirconium dioxide. The disc can be milled into various shapes of prostheses. A CAD/CAM system can be used to produce the prostheses needed from the blank. Neo Denta Zirconia provides an alternate to the gold, porcelain, ceramics and other types of material used in the dental laboratories for dental restoration.
- Indication for Use: Remedial Blanks for the Fabrication of Dental Restoration VII.
- VIII. Technological Characteristics: Since Neo Denta Zirconia is actually relabeled product of the predicate device, Sagemax Z-Blank, Neo Denta Zirconia shares the same technological characteristic with the product of Sagemax. The dimensions, the material, the chemical composition and all other properties of Neo Denta Zirconia are the same compared to Sagemax Z-Blank. The only difference is the design of the packaging material.
- IX. Nonclinical Testing: Particle size was measured by laser scanning, Energy Dispersive Spectrometry (EDS) & X-ray EV for chemical composition, microstructure, surface condition and abnormalities, 1-CR value was determined using the Xrite Color i7 and UV Spectrophotometer, and an Autograph strength test machine for flexural strength and toughness, by determining breakage points in 3 point and biaxial flexural tests.
- ×. Clinical Testing: Clinical testing was not performed for Neo Denta Zirconia since there is no difference in technological characteristics when compared to its predicate.
- XI. Substantial Equivalence: Neo Denta Zirconia is the relabeled product of Sagemax Z-Blank, which is cleared by the 510(k) process with the number Z062695, and with the same intended use with Sagemax Z-Blank. Therefore, Neo Denta Zirconia is substantially equivalent in safety and effectiveness to the predicate device.

OCT 2 1 2013

{1}------------------------------------------------

Image /page/1/Picture/1 description: The image shows a circular logo for the Department of Health & Human Services - USA. The logo features the department's emblem, which consists of a stylized caduceus-like symbol with three wavy lines, representing health and human services. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the emblem in a circular fashion.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

October 21, 2013

Neo Group Ltd. C/O Mr. Mike Adams Director of R&D and Manufacturing Q1D, G/F, Kaiser Estate 3td Phase 18 Man Lok Street, Hung Hom Kowloon, Hong Kong REPUBLIC OF CHINA

Re: K130198

Trade/Device Name: Neo Denta Zirconia Regulation Number: 21 CFR 872.6660 Regulation Name: Porcelain Powder for Clinical Use Regulatory Class: II Product Code: EIH Dated: July 24, 2013 Received: July 29, 2013

Dear Mr. Adams:

We have reviewed vour Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{2}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

## Mary Singuiner -S

Kwame Ulmer M.S. Acting Division Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

{3}------------------------------------------------

Page 3 – Mr. Adams

.

. . . .

ﻣﻴﺮ ﻣ

.

: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :

:

.

:

Enclosure

{4}------------------------------------------------

K130198

## Indication for Use Statement

510(k) Number (if known): NA

Device Name: Neo Denta zirconia

Indications For Use: Remedial Blanks for the Fabrication of Dental Restoration

> Prescription Use _ _ X AND/OR Over-The-Counter Use __________________________________________________________________________________________________________________________________________________ (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

> > Concurrence of CDRH, Office of Device Evaluation (ODE)

Mary S. Runner -S

Susan R DOS, MA 2013.10.21

15:55:08:04'00'

9

---

**Source:** [https://fda-staging.innolitics.com/device/K130198](https://fda-staging.innolitics.com/device/K130198)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com